Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cigna ( (CI) ) has issued an announcement.
On June 2, 2025, The Cigna Group announced the appointment of Michael J. Hennigan to its Board of Directors. Hennigan, who has a robust background in the energy sector, is expected to bring valuable strategic insights and leadership to Cigna, aiding in its mission to improve healthcare experiences and drive growth.
The most recent analyst rating on (CI) stock is a Buy with a $376.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
Cigna’s strong revenue growth and strategic initiatives are offset by modest profitability and valuation concerns. The positive momentum in technical indicators and confidence in earnings guidance support a favorable outlook, balanced by challenges in cost management and valuation metrics.
To see Spark’s full report on CI stock, click here.
More about Cigna
The Cigna Group is a global health company dedicated to enhancing individual and community vitality through innovative health solutions. It operates under brands such as Cigna Healthcare and Evernorth Health Services, with a presence in over 30 countries and more than 190 million customer relationships worldwide.
Average Trading Volume: 1,801,343
Technical Sentiment Signal: Hold
Current Market Cap: $84.59B
See more data about CI stock on TipRanks’ Stock Analysis page.